IMMUNOLOGIC BIOMARKER DYNAMICS IN CHRONIC HEPATITIS B: INSIGHTS FROM A PHASE 2A OPEN- LABEL STUDY ON COMBINATION THERAPIES WITH SMALL INTERFERING RNA, SELGANTOLIMOD, AND NIVOLUMAB
HEPATOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined